No description
-
2009 (v1)PublicationUploaded on: April 14, 2023
-
2005 (v1)Publication
No description
Uploaded on: March 27, 2023 -
1996 (v1)Publication
Autologous peripheral blood progenitor cells (PBPC) rescue after high-dose chemotherapy has been used progressively as a form of treatment in some solid and hematologic tumors. This increasing use can be explained by both advantages of PBPC rescue over bone marrow rescue (decrease in the duration of marrow aplasia, reduction of platelet...
Uploaded on: May 12, 2023 -
2000 (v1)Publication
No description
Uploaded on: April 14, 2023 -
1997 (v1)Publication
Anemia is a common complication observed in cancer patients. Its etiology is multifactorial and its severity depends on patient characteristics, type and stage of neoplasia, type of used chemotherapy. Erythropoietin can be effective by counteracting two of the main causes of anemia in cancer patients undergoing chemotherapy: 1. Myelosuppression...
Uploaded on: May 12, 2023